Sana Biotechnology, Inc. — Director's Dealing 2021

Feb 4, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Sana Biotechnology, Inc. (SANA)
CIK: 0001770121
Period of Report: 2021-02-03

Reporting Person: von Maltzahn Geoffrey (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A-2 Convertible Preferred Stock	$		Common Stock (1464488)		Direct
Series A-2 Convertible Preferred Stock	$		Common Stock (366122)		Indirect

Footnotes

F1: The shares of Issuer's Preferred Stock automatically convert into shares of Issuer's Common Stock, for no additional consideration, on a 1-for-1 basis immediately prior to the consummation of Issuer's initial public offering.

F2: The expiration date is not relevant to the conversion of these securities.